Insider · CIK 0001561958
Yann Echelard
Files at TGTX (TG THERAPEUTICS, INC.). First filing Nov 7, 2024, latest Nov 25, 2025.
In brief
Yann Echelard files SEC Form 4 as director at TGTX (TG THERAPEUTICS, INC.). Since Nov 7, 2024, Yann Echelard has reported 0 open-market buys worth $0 and 3 open-market sells worth $1.0M, the latest filed on Nov 25, 2025.
A track record needs three past buys with six months of prices behind them; Yann Echelard has 0, so none is measured yet.
The newest scored trade: sold $163k of TGTX on Nov 24, 2025, filed Nov 25, 2025, scored 26 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $163k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TGTX: TG THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | TGTXsell TG THERAPEUTICS, INC. | $163k 5,000 shares | -2% | +21% from low-30% from high | |
| 30Weak | TGTXsell TG THERAPEUTICS, INC. | $369k 10,000 shares | -4% | +69% from low-21% from high | |
| 48Moderate | TG THERAPEUTICS, INC. | $490k 20,000 shares | -8% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 24, 2025 | TGTX TG THERAPEUTICS, INC. | 5,000 0.00% of outstanding | $163k | Nov 24, 2025 | none |
| Jun 13, 2025 | TGTX TG THERAPEUTICS, INC. | 10,000 0.01% of outstanding | $369k | Jun 13, 2025 | none |
| Nov 5, 2024 | TGTX TG THERAPEUTICS, INC. | 20,000 0.01% of outstanding | $490k | Nov 5, 2024 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | TGTX TG THERAPEUTICS, INC. | AGrant or award Stock Tracking Unitderivative | +8,325 | $0.00 | $0 | 8,325 | Jun 15, 2026 |
| Nov 24, 2025 | TGTX TG THERAPEUTICS, INC. | SOpen-market sale Common Stock | -5,000 | $32.57 | $163k | 223,816 | Nov 25, 2025 |
| Jun 12, 2025 | TGTX TG THERAPEUTICS, INC. | AGrant or award Common Stock | +14,718 | $0.00 | $0 | 238,816 | Jun 16, 2025 |
| Jun 13, 2025 | TGTX TG THERAPEUTICS, INC. | SOpen-market sale Common Stock | -10,000 | $36.94 | $369k | 228,816 | Jun 16, 2025 |
| Nov 5, 2024 | TGTX TG THERAPEUTICS, INC. | SOpen-market sale Common Stock | -20,000 | $24.48 | $490k | 224,098 | Nov 7, 2024 |
Questions about Yann Echelard
Answered from the filings on this page, as of the latest one.
Is Yann Echelard buying or selling?
In the last 12 months Yann Echelard reported 0 open-market buys worth $0 and 1 open-market sell worth $163k on SEC Form 4; the latest was sold $163k of TGTX on Nov 24, 2025. Grants, option exercises and tax withholding are not counted.
How did Yann Echelard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yann Echelard has 0.
Where does Yann Echelard file Form 4?
Yann Echelard has filed Form 4 at TGTX (TG THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.